| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2008 | EP1912638A2 Composition of n-3 fatty acids having high concentration of epa and/or dha and containing n-6 fatty acids |
| 04/23/2008 | EP1912637A2 Inhibitors of egln3 activity for the treatment of neurodegenerative disorders |
| 04/23/2008 | EP1912635A2 Use of chk2 kinase inhibitors for cancer treatment |
| 04/23/2008 | EP1912634A2 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity |
| 04/23/2008 | EP1912633A2 Methods and compositions for inhibition of vascular permeablility |
| 04/23/2008 | EP1912632A2 Compositions for treating or preventing obesity and insulin resistance disorders |
| 04/23/2008 | EP1912631A2 Diltiazem controlled release formulation and method of manufacture |
| 04/23/2008 | EP1912630A2 Compositions and methods for the reduction of post-operative pain |
| 04/23/2008 | EP1912623A2 Estrogen compositions and therapeutic methods of use thereof |
| 04/23/2008 | EP1912621A1 Pharmaceutical composition containing indometacin and/or acemetacin |
| 04/23/2008 | EP1912499A2 Preparation of montelukast |
| 04/23/2008 | EP1812412B1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same |
| 04/23/2008 | EP1802578B1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 04/23/2008 | EP1763339B1 Oral antimicrobial pharmceutical compositions |
| 04/23/2008 | EP1718648B1 Tricyclic imidazopyridines and intermediates for the synthesis thereof |
| 04/23/2008 | EP1716150B1 Substituted heterocyclic compounds and methods of use |
| 04/23/2008 | EP1689493A4 Calcitonin gene related peptide receptor antagonists |
| 04/23/2008 | EP1675557B1 Composition comprising a sesquiterpene lactone |
| 04/23/2008 | EP1635828B1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 04/23/2008 | EP1618117B1 Tumor selective and biodegradable polyphosphazene-platinum(ii) conjugate antitumor agent, and preparation method thereof |
| 04/23/2008 | EP1615935A4 Phosphate derivatives |
| 04/23/2008 | EP1615896B1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 04/23/2008 | EP1597398B1 Method of diagnostic of mastocytosis |
| 04/23/2008 | EP1597263B1 Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide a |
| 04/23/2008 | EP1581094A4 Kits and methods for assessing skin health |
| 04/23/2008 | EP1578431A4 Fat regulation |
| 04/23/2008 | EP1578430A4 Treatment of diabetes |
| 04/23/2008 | EP1497269B1 Substituted 2-phenyl-3(2h)-pyridazinones |
| 04/23/2008 | EP1476141B1 Tamper-resistant transdermal opioid delivery devices |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1420643B1 Enhancement of transfection of dna into the liver |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP1372673B1 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1305312B1 Tartrate salts of thiazolidinedione derivative |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1251871B1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and as adjuvants an immunogenic oligodeoxynucleotide and a polycationic polypeptide |
| 04/23/2008 | EP1238071B1 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses |
| 04/23/2008 | EP1220921B1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/23/2008 | EP1219612B1 2-imino-1,3-thiazine derivatives |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP1211305B1 Fat compositions |
| 04/23/2008 | EP1162977B1 (androst-5-en-17beta-yl)alkyl sulfoxides and sulfones and their use for the control of fertility |
| 04/23/2008 | EP1142591B1 Gene carriers |
| 04/23/2008 | EP1061962B1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | EP0998459B1 Pyridine derivatives |
| 04/23/2008 | EP0984928B1 Heterocyclic nitrato derivatives |
| 04/23/2008 | EP0975739B1 Stimulation, culture and preservation of pancreatic and other cells |
| 04/23/2008 | EP0763116B2 Recombinant viruses, preparation and use thereof in gene therapy |
| 04/23/2008 | CN101166751A Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 04/23/2008 | CN101166750A Therapeutic furopyrimidines and thienopyrimidines |
| 04/23/2008 | CN101166749A 6-11 bridged oxime erythromycin derivatives |
| 04/23/2008 | CN101166745A Novel thienopyridine compounds, and methods of use thereof |
| 04/23/2008 | CN101166744A Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/23/2008 | CN101166743A Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha] imidazole-3-sulfonic acid |
| 04/23/2008 | CN101166742A Novel lactam compound |
| 04/23/2008 | CN101166740A Imidazo (1,2-a) pyridine derivatives useful as peptide deformylase (PDF) inhibitors |
| 04/23/2008 | CN101166739A Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof |
| 04/23/2008 | CN101166738A Novel crystalline forms of tiotropium bromide |
| 04/23/2008 | CN101166736A Polymorph form II of tanaproget |
| 04/23/2008 | CN101166735A Novel oxadiazole derivatives and their medical use |
| 04/23/2008 | CN101166734A Novel aminopyridine compounds having Syk inhibitory activity |
| 04/23/2008 | CN101166733A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 04/23/2008 | CN101166732A Cyanopyridine derivative and use thereof as medicine |
| 04/23/2008 | CN101166730A Cinnoline compounds and their use as liver X receptor modilators |
| 04/23/2008 | CN101166723A New compound for the treatinginflammatory disease |
| 04/23/2008 | CN101166721A 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 04/23/2008 | CN101166720A Activator for peroxisome proliferator activating receptor delta |
| 04/23/2008 | CN101166719A Bcrp/abcg2抑制剂 Bcrp / abcg2 inhibitors |
| 04/23/2008 | CN101166718A Androgen modulators |
| 04/23/2008 | CN101166706A Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same |
| 04/23/2008 | CN101166543A Composition containing antidementia agent |
| 04/23/2008 | CN101166539A Compositions and methods involving MDA-7 for the treatment of cancer |
| 04/23/2008 | CN101166537A Ex vivo gene expression in whole blood as a model of assessment of individual variation to dietary supplements |
| 04/23/2008 | CN101166534A Therapeutic agent for chronic obstructive pulmonary disease |
| 04/23/2008 | CN101166533A Micronized tanaproget and compostions containing same |
| 04/23/2008 | CN101166532A Micronized tanaproget, compositions, and methods of preparing the same |
| 04/23/2008 | CN101166531A Medicinal preparation for percutaneous absorption |
| 04/23/2008 | CN101166529A Benzotriazole derivatives as cannabinoid receptor antagonists |
| 04/23/2008 | CN101166528A Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (PEG2) |
| 04/23/2008 | CN101166527A Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 04/23/2008 | CN101166526A Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either in combination with a proteasome inhibitor |
| 04/23/2008 | CN101166525A Soap scent patch and treatment for muscle spasm and pain |
| 04/23/2008 | CN101166524A 氨基酸衍生物 Amino acid derivatives |
| 04/23/2008 | CN101166523A Methods of treating atherosclerosis |
| 04/23/2008 | CN101166522A Antibacterial 5,5'-disubstituted 3,3'-dialkoxy-2,2'-dihydroxy-1,1'-biphenyl compounds and related methods |
| 04/23/2008 | CN101166521A Compositions containing micronized tanaproget prepared by wet granulation |
| 04/23/2008 | CN101166519A Dosage forms of risedronate |
| 04/23/2008 | CN101166517A Extrusion process for making compositions with poorly compressible therapeutic compounds |
| 04/23/2008 | CN101166516A Stable pharmaceutical formulations of zonisamide and methods for their manufacture |
| 04/23/2008 | CN101166515A Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions |
| 04/23/2008 | CN101166514A Injectable depot formulations and methods for providing sustained release of nanoparticle compositions |
| 04/23/2008 | CN101166510A External preparation for skin |
| 04/23/2008 | CN101166429A Alimentation composition |
| 04/23/2008 | CN101166428A Nutrition with lipids and non-digestible saccharides |
| 04/23/2008 | CN101165071A Clexane and preparation method thereof |
| 04/23/2008 | CN101165063A Meliacarpinin derivatives, preparation method and use thereof |
| 04/23/2008 | CN101165053A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 04/23/2008 | CN101165052A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |